Correlation Between Inozyme Pharma and Edesa Biotech
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Edesa Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Edesa Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Edesa Biotech, you can compare the effects of market volatilities on Inozyme Pharma and Edesa Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Edesa Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Edesa Biotech.
Diversification Opportunities for Inozyme Pharma and Edesa Biotech
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inozyme and Edesa is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Edesa Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edesa Biotech and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Edesa Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edesa Biotech has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Edesa Biotech go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Edesa Biotech
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Edesa Biotech. In addition to that, Inozyme Pharma is 1.01 times more volatile than Edesa Biotech. It trades about -0.06 of its total potential returns per unit of risk. Edesa Biotech is currently generating about -0.05 per unit of volatility. If you would invest 467.00 in Edesa Biotech on November 9, 2024 and sell it today you would lose (272.00) from holding Edesa Biotech or give up 58.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Edesa Biotech
Performance |
| Timeline |
| Inozyme Pharma |
| Edesa Biotech |
Inozyme Pharma and Edesa Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Edesa Biotech
The main advantage of trading using opposite Inozyme Pharma and Edesa Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Edesa Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edesa Biotech will offset losses from the drop in Edesa Biotech's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Edesa Biotech vs. SAB Biotherapeutics | Edesa Biotech vs. Senti Biosciences | Edesa Biotech vs. Cingulate | Edesa Biotech vs. Indaptus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |